| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 19167437 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 20066125 | ||
| Pubmed | 1.71e-05 | 10 | 22 | 2 | 32161359 | ||
| Pubmed | Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. | 1.88e-05 | 82 | 22 | 3 | 31073041 | |
| Pubmed | 8.94e-05 | 750 | 22 | 5 | 11230166 | ||
| Pubmed | 1.43e-04 | 28 | 22 | 2 | 24491816 | ||
| Pubmed | Genome-wide association study of primary dentition pit-and-fissure and smooth surface caries. | 2.79e-04 | 39 | 22 | 2 | 24556642 | |
| Pubmed | 3.72e-04 | 45 | 22 | 2 | 22696295 | ||
| Pubmed | 5.17e-04 | 251 | 22 | 3 | 29031500 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q33 | 4.32e-03 | 205 | 22 | 2 | chr2q33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 2.14e-02 | 473 | 22 | 2 | chr17q21 | |
| Coexpression | GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP | 1.45e-05 | 200 | 20 | 4 | M6795 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.69e-05 | 208 | 20 | 4 | M39233 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-06 | 185 | 21 | 4 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-06 | 186 | 21 | 4 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-06 | 187 | 21 | 4 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-06 | 188 | 21 | 4 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-06 | 190 | 21 | 4 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.82e-06 | 192 | 21 | 4 | 35557254738844c27ffcd00f3287fbcc0a4d0f3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-06 | 193 | 21 | 4 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-06 | 193 | 21 | 4 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-06 | 193 | 21 | 4 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-06 | 193 | 21 | 4 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-06 | 194 | 21 | 4 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.14e-06 | 200 | 21 | 4 | 3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.14e-06 | 200 | 21 | 4 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.14e-06 | 200 | 21 | 4 | 97a010a1b6d551239cf6ea5a43319fb413ff180e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.14e-06 | 200 | 21 | 4 | 8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.14e-06 | 200 | 21 | 4 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.14e-06 | 200 | 21 | 4 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 6.70e-05 | 170 | 21 | 3 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.82e-05 | 171 | 21 | 3 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-05 | 176 | 21 | 3 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.43e-05 | 176 | 21 | 3 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.56e-05 | 177 | 21 | 3 | 2b675840b7d2bb536c2c600936733bd9e97e7120 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.81e-05 | 179 | 21 | 3 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.94e-05 | 180 | 21 | 3 | 455d1e3ccf2ab609954f3b870e8f514ddca735f4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-05 | 180 | 21 | 3 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.21e-05 | 182 | 21 | 3 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.21e-05 | 182 | 21 | 3 | 08aff7112c9dac0ef5540300516a604782b21169 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.34e-05 | 183 | 21 | 3 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 8.48e-05 | 184 | 21 | 3 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-05 | 184 | 21 | 3 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.61e-05 | 185 | 21 | 3 | 739260f8abebaf10a5cc49d91726278579e26170 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.89e-05 | 187 | 21 | 3 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.03e-05 | 188 | 21 | 3 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.18e-05 | 189 | 21 | 3 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 189 | 21 | 3 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.18e-05 | 189 | 21 | 3 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-05 | 189 | 21 | 3 | fcc3713e8200d51074f709f3360fb36efb0a639f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 189 | 21 | 3 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.18e-05 | 189 | 21 | 3 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.18e-05 | 189 | 21 | 3 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 190 | 21 | 3 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 190 | 21 | 3 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 190 | 21 | 3 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 190 | 21 | 3 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.32e-05 | 190 | 21 | 3 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 190 | 21 | 3 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 190 | 21 | 3 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 190 | 21 | 3 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 190 | 21 | 3 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-05 | 191 | 21 | 3 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-05 | 191 | 21 | 3 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.62e-05 | 192 | 21 | 3 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.62e-05 | 192 | 21 | 3 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.62e-05 | 192 | 21 | 3 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 9.76e-05 | 193 | 21 | 3 | beb862d38b88572836b0a797c8efef7a2492e0b9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.76e-05 | 193 | 21 | 3 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.76e-05 | 193 | 21 | 3 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.76e-05 | 193 | 21 | 3 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.76e-05 | 193 | 21 | 3 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.76e-05 | 193 | 21 | 3 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.76e-05 | 193 | 21 | 3 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.76e-05 | 193 | 21 | 3 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.76e-05 | 193 | 21 | 3 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.76e-05 | 193 | 21 | 3 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.76e-05 | 193 | 21 | 3 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.76e-05 | 193 | 21 | 3 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.76e-05 | 193 | 21 | 3 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.76e-05 | 193 | 21 | 3 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.91e-05 | 194 | 21 | 3 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.91e-05 | 194 | 21 | 3 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.91e-05 | 194 | 21 | 3 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.01e-04 | 195 | 21 | 3 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 197 | 21 | 3 | bed8a9b73af5caee51b1232b31c24a59353658df | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 197 | 21 | 3 | b7d5073d44aa1e2cb83ea8d8104c5ed662665755 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.04e-04 | 197 | 21 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | BAL-Control-cDC_5|Control / Compartment, Disease Groups and Clusters | 1.04e-04 | 197 | 21 | 3 | 8a3fe59be3ed1f0254cc8c60b99c840193370efb | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.05e-04 | 198 | 21 | 3 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.05e-04 | 198 | 21 | 3 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-04 | 198 | 21 | 3 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-04 | 199 | 21 | 3 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.07e-04 | 199 | 21 | 3 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 1.07e-04 | 199 | 21 | 3 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 21 | 3 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 21 | 3 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 1.08e-04 | 200 | 21 | 3 | deeed668b129e66156b5f6abe1a07a9bf842a14d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| Computational | Genes in the cancer module 37. | 9.39e-04 | 471 | 11 | 4 | MODULE_37 | |
| Computational | Genes in the cancer module 136. | 1.10e-03 | 491 | 11 | 4 | MODULE_136 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.14e-03 | 50 | 11 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_10 | |
| Computational | Genes in the cancer module 69. | 1.42e-03 | 526 | 11 | 4 | MODULE_69 | |
| Disease | mood instability measurement | 2.33e-06 | 128 | 22 | 4 | EFO_0008475 | |
| Disease | Myocardial Ischemia | 8.23e-06 | 176 | 22 | 4 | C0151744 | |
| Disease | myocardial infarction (is_implicated_in) | 5.39e-05 | 99 | 22 | 3 | DOID:5844 (is_implicated_in) | |
| Disease | puberty onset measurement | 1.08e-04 | 125 | 22 | 3 | EFO_0005677 | |
| Disease | worry measurement | 2.00e-04 | 154 | 22 | 3 | EFO_0009589 | |
| Disease | unipolar depression, bipolar disorder | 2.07e-04 | 156 | 22 | 3 | EFO_0003761, MONDO_0004985 | |
| Disease | pit and fissure surface dental caries | 3.11e-04 | 35 | 22 | 2 | EFO_0006338 | |
| Disease | neuroticism measurement | 4.67e-04 | 909 | 22 | 5 | EFO_0007660 | |
| Disease | Thrombus | 5.38e-04 | 46 | 22 | 2 | C0087086 | |
| Disease | smoking behaviour measurement | 5.82e-04 | 222 | 22 | 3 | EFO_0005671 | |
| Disease | Thrombosis | 6.11e-04 | 49 | 22 | 2 | C0040053 | |
| Disease | systemic scleroderma (is_marker_for) | 7.15e-04 | 53 | 22 | 2 | DOID:418 (is_marker_for) | |
| Disease | feeling emotionally hurt measurement | 7.98e-04 | 56 | 22 | 2 | EFO_0009599 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 8.26e-04 | 57 | 22 | 2 | DOID:10652 (implicated_via_orthology) | |
| Disease | Cardiomyopathies, Primary | 1.21e-03 | 69 | 22 | 2 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 1.21e-03 | 69 | 22 | 2 | C0036529 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.42e-03 | 75 | 22 | 2 | DOID:1059 (implicated_via_orthology) | |
| Disease | household income | 1.44e-03 | 304 | 22 | 3 | EFO_0009695 | |
| Disease | coronary artery disease | 1.59e-03 | 1194 | 22 | 5 | EFO_0001645 | |
| Disease | post-traumatic stress disorder symptom measurement | 1.70e-03 | 82 | 22 | 2 | EFO_0008535 | |
| Disease | Alveolitis, Fibrosing | 1.74e-03 | 83 | 22 | 2 | C4721507 | |
| Disease | FEV/FEC ratio | 1.80e-03 | 1228 | 22 | 5 | EFO_0004713 | |
| Disease | Pulmonary Fibrosis | 1.82e-03 | 85 | 22 | 2 | C0034069 | |
| Disease | vital capacity | 1.86e-03 | 1236 | 22 | 5 | EFO_0004312 | |
| Disease | Reperfusion Injury | 2.00e-03 | 89 | 22 | 2 | C0035126 | |
| Disease | grip strength measurement | 2.16e-03 | 350 | 22 | 3 | EFO_0006941 | |
| Disease | complement factor D measurement | 2.18e-03 | 93 | 22 | 2 | EFO_0020283 | |
| Disease | Myocardial Infarction | 2.27e-03 | 95 | 22 | 2 | C0027051 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TFQQNSLNWMKKLSP | 351 | P01019 | |
| NPAMQEKKRSSIWQF | 541 | O60271 | |
| CPMNRYSAQKQFWKA | 61 | Q14643 | |
| PSMYRHQIFSWKNKQ | 191 | Q8IY21 | |
| INKNSWFFGPEMNSR | 341 | Q9P2G9 | |
| MKYWANFARTGNPND | 496 | Q5XG92 | |
| FQSMLKSQWQNKPFD | 681 | Q7Z3B3 | |
| PFKEVQWNKMEGRNF | 621 | Q9NVC6 | |
| KARKQCLWFPFNSMS | 91 | P14210 | |
| FPWMKESRQNSKQKN | 161 | P31249 | |
| QSFAQSPWDFMRKNK | 1066 | Q8WZ74 | |
| NAKFSIMPAWQKFSD | 716 | Q6ZU35 | |
| KHWKENMFTPFFSAQ | 6 | A6NGH7 | |
| FTFSNSDMNWARKAP | 46 | A0A0C4DH30 | |
| WKRKNTKSMNFDNPV | 851 | Q14114 | |
| RDFNKTFWNQMQKIF | 961 | Q9H195 | |
| QSFAEKNIFQSRKMW | 91 | Q8TBE7 | |
| KMNNKAGSFFWNLRQ | 16 | Q9NYY8 | |
| GSRWKSMSNQEKQPY | 656 | P35712 | |
| FMEGNQNTPRFMWLK | 231 | Q15111 | |
| GFFVQMQWSKVTNKI | 51 | P40200 | |
| SSAWKQFTQMKPDAS | 1721 | P31629 |